11/06/2024 - Adaptive Biotechnologies Corporation: Submission of Matters to a Vote of Security Holders Form 8 K

[X]
Submission of matters to a vote of security holders form 8 k

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 7, 2024, Adaptive Biotechnologies Corporation (the "Company") held its annual meeting of shareholders (the "Annual Meeting") pursuant to notice duly given. Three proposals were presented for voting: Proposal 1: election of two Class II directors to the Board of Directors (Peter Neupert and Michelle Griffin); Proposal 2: an advisory request concerning compensation for the Company's 2023 named executive officers; and, Proposal 3: ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. Each of the proposals was described in detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 26, 2024. A quorum of the shareholders voted by the conclusion of the Annual Meeting. The final results of the voting are set forth below.

Proposal 1: Election of Class II Directors

Peter Neupert

Votes Submitted

As % of Proposal Votes

Broker Non Vote

For

82,704,811

69.15 %

14,893,022

Against

-

-

Withhold/Abstain

36,895,764

30.85 %

Michelle Griffin

Votes Submitted

As % of Proposal Votes

Broker Non Vote

For

99,854,001

82.93 %

14,080,001

Against

-

-

Withhold/Abstain

20,559,595

17.07 %

Proposal 2: Advisory Vote Concerning the 2023 Compensation of the Company's Named Executive Officers

Votes Submitted

As % of Proposal Votes

Broker Non Vote

For

103,594,016

86.00 %

14,033,887

Against

15,410,744

12.79 %

Withhold/Abstain

1,454,950

1.21 %

Proposal 3: Ramification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2024

Votes Submitted

As % of Proposal Votes

Broker Non Vote

For

133,954,711

99.60 %

0

Against

339,767

0.25 %

Withhold/Abstain

199,119

0.15 %

Disclaimer

Adaptive Biotechnologies Corporation published this content on 11 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 June 2024 20:16:28 UTC.

MoneyController ti propone anche

Condividi